Statements of Operations (USD $)	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Revenues:
Product sales	$ 530	$ 8,395
Sublicense fees	0	50,000
Total revenues	530	58,395
Cost of revenues:
Product sales	212	4,354
Total cost of revenues	212	4,354
Gross margin	318	54,041
Operating expenses:
Research and development expenses	199,599	281,107
Selling, general and administrative expenses	355,327	918,814
Total operating expenses	554,926	1,199,921
Operating loss	(554,608)	(1,145,880)
Other income (expense):
Gain on debt conversion	15,220
Change in fair value of derivatives	44,096	36,468
Interest expense	(155,555)	(211,718)
Other income		7,357
Net loss	(650,847)	(1,313,773)
Preferred stock dividend	(30,851)	(16,956)
Net loss applicable to common shareholders	$ (681,698)	$ (1,330,729)
Basic and diluted net loss per average share available to common shareholders (in Dollars per share)	$ (0.01)	$ (0.02)
Weighted average common shares outstanding – basic and diluted (in Shares)	73,367,810	65,028,701